More Time to SORT OUT Clinical Outcomes After First-Generation Drug-Eluting Stents: Related Versus Unrelated Events.
Gill Heart Institute and Division of Cardiovascular Medicine, University of Kentucky, Lexington, Kentucky. Electronic address: moliterno@uky.edu.
David J
DJ
Moliterno
Gill Heart Institute and Division of Cardiovascular Medicine, University of Kentucky, Lexington, Kentucky.
Khaled M
KM
Ziada
D054855:Drug-Eluting Stents; D000068338:Everolimus; D017239:Paclitaxel; D011897:Random Allocation; D020123:Sirolimus
D000068338:Everolimus; D017239:Paclitaxel; D020123:Sirolimus
angioplasty; coronary disease; stent thrombosis; survival